| Volume | 413,431 |
| Open | 1.560 |
| Bid (Size) | 1.620 (1,700) |
| Ask (Size) | 1.630 (2,500) |
| Prev. Close | 1.550 |
| Today's Range | 1.555 - 1.655 |
| 52wk Range | 1.400 - 2.610 |
| Shares Outstanding | 31,056,238 |
| Dividend Yield | N/A |
Inhibikase Therapeutics, Inc. - Common Stock (IKT) traded between $1.40 and $2.61 over the past 52 weeks and last traded at $1.63, 37.5% below its 52-week high. Over the past week it ranged between $1.43 and $1.73.
IKT was +2.5% over the past year, -15.1% over six months, -16.4% year to date, +4.2% in the last week.
Over the past 12 months IKT returned +2.5% versus DIA (Dow) +10.7%, SPY (S&P 500) +11.5%, QQQ (Nasdaq 100) +10.8% and IWM (Russell 2000) +16.0%.
IKT most recently traded 413,431 shares against a 3-month average daily volume of 562.2K.